Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. (VRDN) stock FAQs
Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.
What is Viridian Therapeutics, Inc. (VRDN) stock price today?
As of Dec 15, 2025, 8:59 PM UTC, Viridian Therapeutics, Inc. (VRDN) stock is trading at $33.03. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date VRDN stock quotes for informed trading decisions.
What is Viridian Therapeutics, Inc.'s market capitalization?
Viridian Therapeutics, Inc. (VRDN) has a market capitalization of approximately $2.7B. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Viridian Therapeutics, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the VRDN stock price changes.
What is the 52-week range for Viridian Therapeutics, Inc. stock?
Viridian Therapeutics, Inc. (VRDN) stock has traded in a 52-week range of $9.90 — $34.02. The 52-week range shows the highest and lowest prices at which VRDN traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Viridian Therapeutics, Inc. stock price to this range provides context for recent price action.
How much trading volume does Viridian Therapeutics, Inc. stock have?
Viridian Therapeutics, Inc. (VRDN) stock recently traded approximately 2.2M shares. Trading volume indicates market liquidity and investor interest in VRDN. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Viridian Therapeutics, Inc. stock.
Does Viridian Therapeutics, Inc. pay dividends to shareholders?
Yes, Viridian Therapeutics, Inc. (VRDN) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Viridian Therapeutics, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.
What is Viridian Therapeutics, Inc.'s intraday price range?
Today, Viridian Therapeutics, Inc. (VRDN) stock has traded in a range of $32.76 — $34.04. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring VRDN's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.
Where does AlphaPilot get Viridian Therapeutics, Inc. stock data?
AlphaPilot sources real-time VRDN stock quotes, fundamental financial data, and historical price charts for Viridian Therapeutics, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Viridian Therapeutics, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of VRDN stock performance.